XML 39 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Changes in Equity - USD ($)
shares in Millions, $ in Millions
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Net Unrealized Gains (Losses) on Investments [Member]
Foreign Currency Translation (Losses) Gains [Member]
Noncontrolling Interest
Balance at Dec. 31, 2020 $ 68,328 $ 10 $ 0 $ 69,295 $ 1,336 $ (5,150) $ 2,837
Balance (in shares) at Dec. 31, 2020   946          
Net earnings attributable to UnitedHealth Group common shareholders 17,285     17,285      
Net earnings attributable to nonredeemable noncontrolling interest             360
Net earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest 17,645            
Other comprehensive income (loss) (1,570)       (913) (657)  
Issuances of common stock, and related tax effects (in shares)   8          
Issuances of common stock, and related tax effects 1,100 $ 0 1,100        
Share-based compensation 729   729        
Common share repurchases (in shares)   (13)          
Common share repurchases (5,000) $ 0 (940) (4,060)      
Cash dividends paid on common shares ($7.29 per share, $6.40 per share and $5.60 per share for the years ended December 31, 2023, 2022 and 2021, respectively) (5,280)     (5,280)      
Redeemable noncontrolling interests fair value and other adjustments (995)   (889) (106)      
Acquisition and other adjustments of nonredeemable noncontrolling interests 407           407
Distributions to nonredeemable noncontrolling interests (319)           (319)
Balance at Dec. 31, 2021 75,045 $ 10 0 77,134 423 (5,807) 3,285
Balance (in shares) at Dec. 31, 2021   941          
Net earnings attributable to UnitedHealth Group common shareholders 20,120     20,120      
Net earnings attributable to nonredeemable noncontrolling interest             406
Net earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest 20,526            
Other comprehensive income (loss) (3,009)       (3,201) 192  
Issuances of common stock, and related tax effects (in shares)   7          
Issuances of common stock, and related tax effects 903 $ 0 903        
Share-based compensation $ 875   875        
Common share repurchases (in shares) (14) (14)          
Common share repurchases $ (7,000) $ (1) (1,892) (5,107)      
Cash dividends paid on common shares ($7.29 per share, $6.40 per share and $5.60 per share for the years ended December 31, 2023, 2022 and 2021, respectively) (5,991)     (5,991)      
Redeemable noncontrolling interests fair value and other adjustments 114   114        
Acquisition and other adjustments of nonredeemable noncontrolling interests 374           374
Distributions to nonredeemable noncontrolling interests (387)           (387)
Balance at Dec. 31, 2022 $ 81,450 $ 9 0 86,156 (2,778) (5,615) 3,678
Balance (in shares) at Dec. 31, 2022 934 934          
Net earnings attributable to UnitedHealth Group common shareholders $ 22,381     22,381      
Net earnings attributable to nonredeemable noncontrolling interest             575
Net earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest 22,956            
Other comprehensive income (loss) 1,366       807 559  
Issuances of common stock, and related tax effects (in shares)   6          
Issuances of common stock, and related tax effects 1,231 $ 0 1,231        
Share-based compensation $ 1,027   1,027        
Common share repurchases (in shares) (16) (16)          
Common share repurchases $ (8,059) $ 0 (2,057) (6,002)      
Cash dividends paid on common shares ($7.29 per share, $6.40 per share and $5.60 per share for the years ended December 31, 2023, 2022 and 2021, respectively) (6,761)     (6,761)      
Redeemable noncontrolling interests fair value and other adjustments (201)   (201)        
Acquisition and other adjustments of nonredeemable noncontrolling interests 1,928           1,928
Distributions to nonredeemable noncontrolling interests (516)           (516)
Balance at Dec. 31, 2023 $ 94,421 $ 9 $ 0 $ 95,774 $ (1,971) $ (5,056) $ 5,665
Balance (in shares) at Dec. 31, 2023 924 924